100P Efficacy of enobosarm, a selective androgen receptor (AR) targeting agent, in patients with metastatic AR+/ER+ breast cancer resistant to estrogen receptor targeted agents and CDK 4/6 inhibitor in a phase II clinical study
| Autor: | Palmieri, C., Linden, H., Birrell, S., Lim, E., Schwartzberg, L.S., Rugo, H.S., Cobb, P., Jain, K., Vogel, C., O'Shaughnessy, J., Johnston, S.R.D., Getzenberg, R.H., Barnette, K.G., Steiner, M., Brufsky, A.M., Overmoyer, B. |
|---|---|
| Zdroj: | In Annals of Oncology May 2021 32 Supplement 2:S66-S66 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|